Dr. Dmitry Golovko, MD Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: 3507 104th St, Lubbock, TX 79423 Phone: 806-771-1995 Fax: 806-771-1997 |
Gerald L Hill, M.D. Preventive Medicine - Preventive Medicine/Occupational Environmental Medicine Medicare: Not Enrolled in Medicare Practice Location: 3802 21st St Ste A, Lubbock, TX 79410 Phone: 806-791-1272 Fax: 806-791-1955 |
Mr. Jesus Enrique Hidalgo, M.D. Preventive Medicine - Undersea and Hyperbaric Medicine Medicare: Accepting Medicare Assignments Practice Location: 3601 22nd Pl, Lubbock, TX 79410 Phone: 806-589-5030 |
Dr. Alice Ferrell Pangle, D.O. Preventive Medicine - Preventive Medicine/Occupational Environmental Medicine Medicare: Medicare Enrolled Practice Location: 3303 University Ave, Lubbock, TX 79410 Phone: 806-795-6466 Fax: 806-795-4634 |
Dr. Glenn Michael Shipley, D.O. Preventive Medicine - Preventive Medicine/Occupational Environmental Medicine Medicare: Not Enrolled in Medicare Practice Location: 3401 N University Ave, Lubbock, TX 79415 Phone: 806-741-3609 Fax: 806-741-3604 |
Kelli Knippa, LAT Preventive Medicine - Sports Medicine Medicare: Not Enrolled in Medicare Practice Location: 4202 44th St, Lubbock, TX 79413 Phone: 512-299-6389 |
News Archive
ICTS, the patient recruitment and clinical trial services company, has successfully completed the fifth in a series of rheumatology study recruitment efforts for the same sponsor. Using an integrated approach that centered around a study website, social media, geographically initiated keyword search advertising, and also included site enrollment toolkits, the program exceeded the enrollment timelines established by the sponsor.
Sunlight Research – The Source for Patent Analysis, today announced the release of its comprehensive Stem Cell Industry Report analyzing the U.S. Stem Cell patent landscape. Stem cells are particularly attractive for use as cellular therapies because they self-renew and have the capacity to produce many different specialized cell types.
In a clinical trial, a self-expanding transcatheter aortic valve met the key performance objective of reducing death and stroke in patients with severe aortic stenosis at "extreme risk" for surgery.Results of the COREVALVE EXTREME RISK trial were presented today at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.
Teleflex Incorporated has announced the introduction of Hudson RCI Softech Plus, a line of oxygen cannulas designed to help clinicians improve patient comfort and reduce DEHP exposure.
› Verified 5 days ago